The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1966, 96: 229-238.
Copyright © 1966 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monaco, A. P.
Right arrow Articles by Russell, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monaco, A. P.
Right arrow Articles by Russell, P. S.

Studies on Heterologous Anti-Lymphocyte Serum in Mice

II. Effect on the Immune Response1

Anthony P. Monaco, Mary L. Wood, J. G. Gray and Paul S. Russell

From the Department of Surgery, Harvard Medical School, the General Surgical Services, Massachusetts General Hospital, and the J. Collins Warren Laboratories of the Huntington Memorial Hospital of Harvard University

Abstract

1. Rabbit anti-A/Jax lymphocyte serum (RAMLS) given to A/Jax mice inhibits the primary and, to some extent, the secondary hemagglutinin response to sheep erythrocytes.
2. RAMLS-treated mice show decreased ability to reject first and second set skin allografts and rat skin xenografts.
3. Prolongation of skin allografts by RAMLS is probably due to a central inhibition of the allograft rejection response.
4. The crude {gamma}-globulin fraction extracted from RAMLS is as effective in inhibiting the allograft response as the whole serum.
5. The ability of RAMLS to inhibit the allograft rejection response is not due to the antibodies to mouse {gamma}-globulin present in the RAMLS.
6. RAMLS is a potent biologic reagent for the induction of states of lymphocyte depletion.

Footnotes

1 This work was supported in part by Grants AM 07055, AI 06320, T4 CA 5018 and CRTY 5018 from the United States Public Health Service and by the William F. Milton Fund of the Harvard University.

This is publication No. 1236 of the Cancer Commission of Harvard University.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. Feunou, L. Poulin, C. Habran, A. Le Moine, M. Goldman, and M. Y. Braun
CD4+CD25+ and CD4+CD25- T Cells Act Respectively as Inducer and Effector T Suppressor Cells in Superantigen-Induced Tolerance
J. Immunol., October 1, 2003; 171(7): 3475 - 3484.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Asseman, S. Read, and F. Powrie
Colitogenic Th1 Cells Are Present in the Antigen-Experienced T Cell Pool in Normal Mice: Control by CD4+ Regulatory T Cells and IL-10
J. Immunol., July 15, 2003; 171(2): 971 - 978.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. Graca, S. P. Cobbold, and H. Waldmann
Identification of Regulatory T Cells in Tolerated Allografts
J. Exp. Med., June 17, 2002; 195(12): 1641 - 1646.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Graca, S. Thompson, C.-Y. Lin, E. Adams, S. P. Cobbold, and H. Waldmann
Both CD4+CD25+ and CD4+CD25- Regulatory Cells Mediate Dominant Transplantation Tolerance
J. Immunol., June 1, 2002; 168(11): 5558 - 5565.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Graca, K. Honey, E. Adams, S. P. Cobbold, and H. Waldmann
Cutting Edge: Anti-CD154 Therapeutic Antibodies Induce Infectious Transplantation Tolerance
J. Immunol., November 1, 2000; 165(9): 4783 - 4786.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Umemura, A. P. Monaco, and T. Maki
Donor MHC Class II Antigen Is Essential for Induction of Transplantation Tolerance by Bone Marrow Cells
J. Immunol., May 1, 2000; 164(9): 4452 - 4457.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Honey, S. P. Cobbold, and H. Waldmann
CD40 Ligand Blockade Induces CD4+ T Cell Tolerance and Linked Suppression
J. Immunol., November 1, 1999; 163(9): 4805 - 4810.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Isaacs, J. Greenwood, and H. Waldmann
Therapy with Monoclonal Antibodies. II. The Contribution of Fc{gamma} Receptor Binding and the Influence of CH1 and CH3 Domains on In Vivo Effector Function
J. Immunol., October 15, 1998; 161(8): 3862 - 3869.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
P. B. Stewart and V. Cohen
Antiserum to Lymphocytes and Procarbazine Compared as Immunosuppressants in Mice
Science, May 30, 1969; 164(3883): 1082 - 1083.
[Abstract] [PDF]


Home page
ScienceHome page
A. P. Monaco, W. M. Abbott, H. B. Othersen, R. L. Simmons, M. L. Wood, M. H. Flax, and P. S. Russell
Antiserum to Lymphocytes: Prolonged Survival of Canine Renal Allografts
Science, September 9, 1966; 153(3741): 1264 - 1267.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1966 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1966 by The American Association of Immunologists, Inc. All rights reserved.